一线癌症治疗对女孩和年轻女性冷冻保存卵巢样本中卵泡质量的影响
这项回顾性队列研究纳入2003至2018年间转诊至赫尔辛基、奥斯陆和坦佩雷三个中心进行卵巢组织冷冻保存的43例年轻患者(1-24岁),其中25例在冷冻保存前接受过一线化疗,18例未接受。暴露于一线化疗的患者中,闭锁的原始卵泡和中间卵泡密度显著更高,完整的原始卵泡和中间卵泡尺寸显著更小,培养中类固醇分泌显著受损,间质区胶原含量和DNA损伤更高;未发现休眠卵泡激活增加或卵母细胞核DNA损伤水平升高。
要点
- 一线化疗显著影响卵泡活力、残留完整卵泡尺寸、培养中类固醇分泌及间质区质量。
- 暴露于一线化疗的患者闭锁的原始卵泡和中间卵泡密度显著高于未治疗患者。
- 暴露于一线化疗的患者完整的原始卵泡和中间卵泡尺寸显著小于未治疗患者。
核心结论
- 暴露于一线化疗显著影响卵泡活力、残留完整卵泡的尺寸、培养中的类固醇分泌以及间质区质量。
- 这些观察结果可能提示一线化疗暴露导致卵泡质量和发育能力下降。
- 未发现暴露于化疗的患者休眠卵泡激活增加或卵母细胞核DNA损伤水平升高。
研究设计与样本
- 回顾性队列研究,纳入2003至2018年间转诊至赫尔辛基、奥斯陆和坦佩雷三个中心进行卵巢组织冷冻保存的年轻患者。
- 共纳入43例患者(年龄1-24岁),其中25例在冷冻保存前暴露于一线化疗,18例未暴露。
主要发现
- 暴露于一线化疗的患者闭锁的原始卵泡和中间卵泡密度显著高于未治疗患者。
- 暴露于一线化疗的患者完整的原始卵泡和中间卵泡尺寸显著小于未治疗患者。
- 暴露于一线化疗的患者培养中类固醇产生显著受损,间质区胶原含量和DNA损伤更高。
- 未发现暴露于化疗的患者休眠卵泡激活增加或卵母细胞核DNA损伤水平升高。
临床怎么用
- 作者认为这些数据提示相对安全的治疗对卵巢健康有深远影响,并鼓励在随访研究中进一步探索该效应以优化年轻癌症患者的生育力保存。
局限性
- 两组在年龄方面不均匀,且患者接受了不同治疗,无法区分特定药物的效应。
- 有限的材料可用性不允许对整个患者集进行所有分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does first-line chemotherapy affect the quality of ovarian pre-antral follicles and stromal tissue in a population of young patients? SUMMARY ANSWER: Exposure to first-line chemotherapy significantly impacts follicle viability, size of residual intact follicles, steroid secretion in culture and quality of the stromal compartment. WHAT IS KNOWN ALREADY: First-line chemotherapy is considered to have a low gonadotoxic potential, and as such, does not represent an indication for fertility preservation. Studies investigating the effects of chemotherapy on the quality of ovarian tissue stored for fertility preservation in young patients are limited and the results sometimes contradictory. STUDY DESIGN, SIZE, DURATION: We conducted a retrospective cohort study including young patients referred to three centers (Helsinki, Oslo and Tampere) to perform ovarian tissue cryopreservation for fertility preservation between 2003 and 2018. PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 43 patients (age 1-24 years) were included in the study. A total of 25 were exposed to first-line chemotherapy before cryopreservation, whereas 18 patients were not. Density and size of follicles divided by developmental stages, prevalence of atretic follicles, health of the stromal compartment and functionality of the tissue in culture were evaluated and related to age and chemotherapy exposure. Activation of dormant follicles and DNA damage were also assessed. MAIN RESULTS AND THE ROLE OF CHANCE: Patients exposed to first-line chemotherapy showed a significantly higher density of atretic primordial and intermediary follicles than untreated patients. The intact primordial and intermediary follicles were significantly smaller in size in patients exposed to chemotherapy. Production of steroids in culture was also significantly impaired and a higher content of collagen and DNA damage was observed in the stromal compartment of treated patients. Collectively, these observations may indicate reduced quality and developmental capacity of follicles as a consequence of first-line chemotherapy exposure. Neither increased activation of dormant follicles nor elevated levels of DNA damage in oocyte nuclei were found in patients exposed to chemotherapy. LIMITATIONS, REASONS FOR CAUTION: The two groups were not homogeneous in terms of age and the patients were exposed to different treatments, which did not allow us to distinguish the effect of specific agents. The limited material availability did not allow us to perform all the analyses on the entire set of patients. WIDER IMPLICATION OF THE FINDINGS: This study provides for the first time a comprehensive analysis of the effects of first-line chemotherapy on the health, density and functionality of follicles categorized according to the developmental stage in patients under 24 years of age. When exposed to these treatments, patients were considered at low/medium risk of infertility. Our data suggest a profound impact of these relatively safe therapies on ovarian health and encourages further exploration of this effect in follow-up studies in order to optimize fertility preservation for young cancer patients. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by the Swedish Childhood Cancer Foundation, the Finnish Cancer Society, the Finnish Pediatric Research Foundation, the Väre Foundation for Pediatric Cancer Research, The Swedish Research Council, the Stockholm County Council (ALF project) and Karolinska Institutet. The authors have no conflict of interest to declare.
引用
- Pampanini V, Wagner M, Asadi-Azarbaijani B, et al. Impact of first-line cancer treatment on the follicle quality in cryopreserved ovarian samples from girls and young women. Hum Reprod. 2019. PMID: 31411325. doi:10.1093/humrep/dez125
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。